Explore more publications!

US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on December 6, 2025

Caring Therapists Expands to Port Orange with Lakeside Counseling and Wellness Center Partnership
Dr. Garcia Announces Holiday Gift Discount and Flexible Payment Plans for Biomagnetism Online Training
Inside China's PSA Nitrogen Generator for Laser Cutting Machine: Luoming's Role in Innovation and Sustainability
Bainbridge Health Celebrates a Year of Record Growth & Innovation at ASHP Midyear
Proactive MD Expands Access to Women’s Health and Chronic Disease Care with New Acquisitions
Independence Care of Naples Honored with 2025 Best of Florida Award
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
Sapu Nano 宣布推出基于 Deciparticle™ 技术的生物标志物框架,用于识别最可能对静脉注射 Sapu003(一种依维莫司纳米药物)产生反应的肿瘤
Sapu Nano 宣佈由 Deciparticle™ 驅動的生物標記框架,可識別出最有可能對靜脈注射依維莫司納米藥物 Sapu003 產生反應的腫瘤
Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs
Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting
Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH)…
Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
Sapu Nano 公布新的药代动力学数据显示,与口服给药相比,静脉注射 Sapu003 可将依维莫司的胃肠道积累量减少 67 倍

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions